These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 26205647

  • 1. Results of a national multicentric study on compliance to treatment with various disphosphonate formulations in patients with postmenopausal osteoporosis.
    Vinicola V, Giampà E, Di Bonito M, Ferretti V, Nuvoli G, Paoletti F, Piazzini M, Ranieri M, Tuveri MA.
    Minerva Endocrinol; 2015 Sep; 40(3):187-93. PubMed ID: 26205647
    [Abstract] [Full Text] [Related]

  • 2. Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates.
    Petranova T, Boyanov M, Shinkov A, Petkova R, Intorcia M, Psachoulia E.
    Arch Osteoporos; 2017 Dec 21; 13(1):1. PubMed ID: 29264666
    [Abstract] [Full Text] [Related]

  • 3. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis.
    Cramer JA, Amonkar MM, Hebborn A, Altman R.
    Curr Med Res Opin; 2005 Sep 21; 21(9):1453-60. PubMed ID: 16197664
    [Abstract] [Full Text] [Related]

  • 4. Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women.
    Lai PS, Chua SS, Chew YY, Chan SP.
    J Clin Pharm Ther; 2011 Oct 21; 36(5):557-67. PubMed ID: 21916908
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Once-monthly oral ibandronate in postmenopausal osteoporosis: translation and updated review.
    Rossini M, Viapiana O, Gatti D, Adami S.
    Clin Ther; 2009 Jul 21; 31(7):1497-510. PubMed ID: 19695399
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of novel bisphosphonate dosing regimens in osteoporosis: the role of comparative studies and implications for future studies.
    Cosman F, Borges JL, Curiel MD.
    Clin Ther; 2007 Jun 21; 29(6):1116-27. PubMed ID: 17692726
    [Abstract] [Full Text] [Related]

  • 10. Drug insight: Bisphosphonates for postmenopausal osteoporosis.
    Chapurlat RD, Delmas PD.
    Nat Clin Pract Endocrinol Metab; 2006 Apr 21; 2(4):211-9; quiz following 238. PubMed ID: 16932286
    [Abstract] [Full Text] [Related]

  • 11. Treatment satisfaction in postmenopausal women suboptimally adherent to bisphosphonates who transitioned to denosumab compared with risedronate or ibandronate.
    Palacios S, Agodoa I, Bonnick S, Van den Bergh JP, Ferreira I, Ho PR, Brown JP.
    J Clin Endocrinol Metab; 2015 Mar 21; 100(3):E487-92. PubMed ID: 25514106
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis.
    Bilezikian JP.
    Am J Med; 2009 Feb 21; 122(2 Suppl):S14-21. PubMed ID: 19187808
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) study.
    Emkey R, Delmas PD, Bolognese M, Borges JL, Cosman F, Ragi-Eis S, Recknor C, Zerbini CA, Neate C, Sedarati F, Epstein S.
    Clin Ther; 2009 Apr 21; 31(4):751-61. PubMed ID: 19446148
    [Abstract] [Full Text] [Related]

  • 19. Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis.
    Park JH, Park EK, Koo DW, Lee S, Lee SH, Kim GT, Lee SG.
    BMC Musculoskelet Disord; 2017 Apr 11; 18(1):152. PubMed ID: 28399834
    [Abstract] [Full Text] [Related]

  • 20. Bisphosphonates for prevention of postmenopausal osteoporosis.
    Ravn P.
    Dan Med Bull; 2002 Feb 11; 49(1):1-18. PubMed ID: 11894721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.